Advertisement

Ads Placeholder
Loading...

ObsEva S.A.

OBSN.SWSIX
Healthcare
Biotechnology
CHF0.001
CHF-0.00(-76.92%)
Swiss Market is Open • 10:07

ObsEva S.A. Fundamental Analysis

ObsEva S.A. (OBSN.SW) shows weak financial fundamentals with a PE ratio of -0.00, profit margin of -1.52%, and ROE of -1.46%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position7623.74%
PEG Ratio-0.00
Current Ratio2.23

Areas of Concern

ROE-1.46%
Operating Margin-79.83%
We analyze OBSN.SW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -293.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-293.1/100

We analyze OBSN.SW's fundamental strength across five key dimensions:

Efficiency Score

Weak

OBSN.SW struggles to generate sufficient returns from assets.

ROA > 10%
-1.81%

Valuation Score

Excellent

OBSN.SW trades at attractive valuation levels.

PE < 25
-0.00
PEG Ratio < 2
-0.00

Growth Score

Weak

OBSN.SW faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

OBSN.SW maintains a strong and stable balance sheet.

Debt/Equity < 1
0.36
Current Ratio > 1
2.23

Profitability Score

Weak

OBSN.SW struggles to sustain strong margins.

ROE > 15%
-146.39%
Net Margin ≥ 15%
-1.52%
Positive Free Cash Flow
No

Key Financial Metrics

Is OBSN.SW Expensive or Cheap?

P/E Ratio

OBSN.SW trades at -0.00 times earnings. This suggests potential undervaluation.

-0.00

PEG Ratio

When adjusting for growth, OBSN.SW's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values ObsEva S.A. at 0.02 times its book value. This may indicate undervaluation.

0.02

EV/EBITDA

Enterprise value stands at -0.37 times EBITDA. This is generally considered low.

-0.37

How Well Does OBSN.SW Make Money?

Net Profit Margin

For every $100 in sales, ObsEva S.A. keeps $-1.52 as profit after all expenses.

-1.52%

Operating Margin

Core operations generate -79.83 in profit for every $100 in revenue, before interest and taxes.

-79.83%

ROE

Management delivers $-1.46 in profit for every $100 of shareholder equity.

-1.46%

ROA

ObsEva S.A. generates $-1.81 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.81%

Following the Money - Real Cash Generation

Operating Cash Flow

ObsEva S.A. generates limited operating cash flow of $-29.45M, signaling weaker underlying cash strength.

$-29.45M

Free Cash Flow

ObsEva S.A. generates weak or negative free cash flow of $-29.45M, restricting financial flexibility.

$-29.45M

FCF Per Share

Each share generates $-0.25 in free cash annually.

$-0.25

FCF Yield

OBSN.SW converts -130.79% of its market value into free cash.

-130.79%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.00

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.02

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.009

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.36

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.23

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.46

vs 25 benchmark

ROA

Return on assets percentage

-1.81

vs 25 benchmark

ROCE

Return on capital employed

-1.68

vs 25 benchmark

How OBSN.SW Stacks Against Its Sector Peers

MetricOBSN.SW ValueSector AveragePerformance
P/E Ratio-0.0028.31 Better (Cheaper)
ROE-146.39%699.00% Weak
Net Margin-152.16%-130884.00% (disorted) Weak
Debt/Equity0.360.34 Neutral
Current Ratio2.232775.16 Strong Liquidity
ROA-180.60%-14469.00% (disorted) Weak

OBSN.SW outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews ObsEva S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ